J Kimo Esplin
CIK 1276716 · Exec VP, Strategy & Investment · last filed 2018-08-03
J Kimo Esplin is an Exec VP, Strategy & Investment who has filed 159 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for HUN, was dated Aug 3, 2018. Across all open-market trades the lifetime net is −$22.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.1M across reported positions. 57 SEC filings were submitted jointly with Huntsman CORP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HUN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1400 KEARNS BLVD
PARK CITY, UT 84060
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HUN | Exec VP, Strategy & Investment | 369,210 | $8.43 | $3.11M | -$22.47M | 45 | 2018-08-03 |
| NUTRACEUTICAL INTERNATIONAL CORP (NUTR) Delisted | Director | 0 | — | — | -$119.2K | 112 | 2017-08-24 |
Recent Filings
159 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-08-03 | HUN | Gift (G) | −13,657 | $0 | EDGAR |
| 2018-05-17 | HUN | Sell (S) | −16,106 | -$526.5K | EDGAR |
| 2018-05-17 | HUN | Sell (S) | −34,399 | -$1.09M | EDGAR |
| 2018-02-09 | HUN | Mixed | +3,527 | $0 | EDGAR |
| 2018-02-05 | HUN | Tax (F) | −7,187 | -$233.3K | EDGAR |
| 2017-12-07 | HUN | Mixed | — | -$3.67M | EDGAR |
| 2017-11-01 | HUN | Mixed | — | -$12.40M | EDGAR |
| 2017-08-24 | NUTRACEUTICAL INTERNATIONAL CORP (NUTR) Delisted | Disp (D) | −11,127 | $0 | EDGAR |
| 2017-05-08 | NUTRACEUTICAL INTERNATIONAL CORP (NUTR) Delisted | Grant (A) | +31 | $1.0K | EDGAR |
| 2017-04-10 | NUTRACEUTICAL INTERNATIONAL CORP (NUTR) Delisted | Grant (A) | +32 | $1.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.